查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
生物資訊市場 - 全球及區域分析：按產品/服務、產業、應用和地區分類 - 分析與預測（2025-2035）
市場調查報告書
商品編碼
1885394

生物資訊市場 - 全球及區域分析：按產品/服務、產業、應用和地區分類 - 分析與預測（2025-2035）

Bioinformatics Market - A Global and Regional Analysis: Focus on Product and Services, Sector, Application, and Regional Analysis - Analysis and Forecast, 2025-2035
出版日期: | 出版商: BIS Research | 英文 146 Pages | 商品交期: 1-5個工作天內

價格

全球生物資訊市場到2024年達到 142.3億美元，預計到2035年將顯著成長至 555.4億美元。

這顯示從2025年到2035年，年複合成長率將達到 13.21%。

關鍵市場統計資料
預測期 2025-2035
截至2025年的估值 160.6億美元
2035年預測 555.4億美元
年複合成長率 13.21%

生物資訊學是一門交叉學科，結合了生物學、化學、數學、統計學和電腦科學，用於分析複雜的生物資料。生物資訊學對於理解生物分子的結構、功能和演化非常重要，並在識別疾病的遺傳病因、分析基因表現和研究蛋白質相互作用方面發揮關鍵作用。它對於藥物發現、個人化醫療和闡明代謝通路也非常重要。次世代定序技術的進步導致基因組資料爆炸性成長，大大推動了對生物資訊工具的需求。此外，生物資訊學在精準醫療上的應用也日益廣泛。人工智慧和機器學習的持續進步進一步提高了資料分析的準確性和速度，使生物資訊學成為未來醫療保健、基因組學和生命科學研究的關鍵組成部分，其重要性與日俱增。

市場概覽

生物資訊市場正經歷快速發展，其驅動力來自技術創新以及基因組學和個人化醫療領域不斷成長的投資。 Illumina、Thermo Fisher Scientific 和 QIAGEN 等主要企業提供尖端的定序平台和資料分析工具，引領著生物資訊解決方案的變革，改變醫療保健和製藥行業。策略聯盟和收購也在市場成長中發揮關鍵作用。例如，Illumina 擴大其在亞太地區的商業版圖，而 Thermo Fisher Scientific 則持續創新，開發用於基因組資料分析的雲端基礎生物資訊解決方案。此外，Tempus 和 23andMe 等公司整合生物資訊學工具，用於精準醫療和消費者導向的基因檢測，推動生物資訊學在各個應用領域的普及。這些發展表明，市場對先進生物資訊解決方案的需求日益成長，有助於加速創新，並擴大基因組學、藥物研發和個人化醫療領域的應用範圍。

對產業的影響

生物資訊市場正迅速發展，這主要得益於技術創新以及基因組學和個人化醫療領域不斷成長的投資。Illumina Inc.、Thermo Fisher Scientific Inc.、QIAGEN等主要公司提供尖端的定序平台和資料分析工具，處於生物資訊解決方案的前沿，改變醫療保健和製藥行業。這些領導企業透過整合人工智慧（AI）、機器學習和雲端運算等尖端技術，不斷突破創新邊界，提升生物資訊學能力。人工智慧與生物資訊學的融合革新複雜生物資料的分析方式，使研究人員和臨床醫生能夠在基因組學、蛋白質組學和個人化醫療領域中獲得更快、更準確的洞見。

人工智慧驅動的生物資訊工具實現資料處理和分析的自動化，減少人為錯誤並縮短研發週期。例如，人工智慧模型可以分析海量基因組資料集，並識別出與疾病相關的模式和突變，而使用傳統方法則需要花費更長時間才能發現這些模式和突變。這種快速分析對於推進精準醫療非常重要，精準醫療是指根據個別患者的基因譜量身定做治療方案。此外，機器學習演算法增強預測模型，在藥物發現和患者預後方面實現更準確的預測。

雲端運算在生物資訊領域的應用也帶來了變革性的影響，實現了全球研究團隊之間無縫的資料共用、儲存和協作。這不僅加速了基因組學和藥物研發，還透過提供擴充性、經濟高效的巨量資料分析解決方案，降低了小規模實驗室和機構的進入門檻。此外，這些技術的協同效應改善患者照護，為醫療專業人員提供有關遺傳易感性的可操作資訊，最佳化治療方案，並提高整體醫療服務的效率。

市場區隔：

區隔 1：依產品/服務

  • 生物資訊軟體和工具
  • 生物資訊服務

生物資訊軟體和工具在生物資訊市場（依產品/服務）中主導。

依產品和服務分類，全球生物資訊市場以生物資訊軟體和工具為主導，預計到2024年將佔據61.7%的市場佔有率。生物資訊軟體和工具在管理、分析和解讀複雜的生物資料方面發揮關鍵作用。隨著次世代定序（NGS）等技術產生的資料量不斷成長，這些工具能夠實現高效的資料管理並加速分析流程。 BLAST和GATK等軟體簡化了序列比對、變異檢測和突變檢測等任務，這些任務對於基因組學和個人化醫療非常重要。此外，人工智慧和機器學習的融合提高了分析的準確性和預測能力，有助於檢測基因突變和提案個人化治療方法。 Illumina的BaseSpace Sequence Hub和Galaxy等雲端基礎平台透過促進協作並提供擴充性的資料共用和儲存解決方案，進一步推動了生物資訊學的普及。這些工具對於推進基因組學、藥物發現和精準醫療等領域非常重要，因為它們可以減少人工工作，提高速度，並確保在研究和臨床環境中獲得更準確的結果。

區隔2：依行業

  • 醫學生物技術
  • 動物生物技術
  • 植物生物技術
  • 法醫學醫學工程
  • 其他

醫療生物技術推動生物資訊市場（依領域）

依領域，到2024年，醫療生物技術將以55.2%的市場佔有率引領全球生物資訊市場。醫療生物技術在生物資訊市場的主導源自於其廣泛應用生物資訊學工具，以推動基因治療、個人化醫療和藥物研發等領域的發展。生物資訊學能夠分析大規模基因組資料集，幫助生物技術公司識別與疾病相關的基因突變、生物標記和治療標靶。例如，Illumina的定序平台在醫療生物技術領域非常重要，它提供的精準基因組資料推動了診斷和治療研發的進步。精準醫療領域的領導者Tempus利用生物資訊分析癌症患者的基因譜，並根據個別突變推薦個人化治療方案。此外，作為醫療生物技術核心技術的CRISPR-Cas9基因編輯也依賴生物資訊學進行精準的基因標靶化和檢驗。生物資訊學與醫療生物技術的融合加速了標靶治療的研發，改善了治療效果，並簡化了藥物發現流程。這種協同作用使生物資訊學成為醫學生物技術成功和發展的重要組成部分。

區隔3：依應用

  • 基因組學
  • 蛋白質體學
  • 轉錄組學
  • 代謝體學
  • 其他

基因組學推動生物資訊市場（依應用領域）

依應用領域分類，基因組學將在2024年佔據全球生物資訊市場39.7%的佔有率。基因組學之所以主導生物資訊市場，是因為它會產生龐大而複雜的資料集，需要先進的生物資訊學工具進行精確的分析和解讀。在基因組學領域，生物資訊學對於定序、比對和變異檢測等任務非常重要，這些任務能夠識別基因突變和潛在的治療標靶。例如，Illumina的定序平台在基因組研究和臨床應用中發揮核心作用，提供的資料驅動著個人化醫療和藥物研發。像Tempus這樣的公司利用生物資訊分析基因組資料，實現精準癌症治療，根據基因突變客製化治療方法。此外，生物資訊學工具對於人類基因組計畫和千人基因組計劃等大型基因組計劃也非常重要，這些計畫增進了對遺傳學的理解，並為現代基因組學奠定了基礎。隨著基因組技術的不斷發展，生物資訊學對於分析、解釋和應用基因組資料仍然非常重要，這有助於基因組學在生物資訊市場中確立主導地位。

細分 4：依地區

  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 其他
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 澳洲
    • 韓國
    • 其他
  • 其他地區

預計北美將在生物資訊市場中展現最高的區域成長。

北美在全球生物資訊市場佔據領先地位，預計到2024年將佔全球市場佔有率的約43.5%。北美在生物資訊市場的主導地位得益於其強大的基礎設施、大規模的研發投入以及Illumina、Thermo Fisher Scientific和Qiagen等主要企業的存在。然而，亞太地區是生物資訊學領域成長最快的市場，這主要得益於不斷擴大的醫療保健基礎設施、生物技術和基因組學領域投資的增加以及對個人化醫療日益成長的需求。中國、印度和日本等國家大力投資基因組學研究和生物資訊技術，以滿足不斷成長的醫療保健需求。該地區龐大且多元化的人口為基因組學研究提供了豐富的資料，為精準醫療和藥物研發的進步創造了機會。

全球生物資訊市場最新趨勢

  • 2025年 9月，Thermo Fisher Scientific Inc.宣布與 BenchSci 建立策略夥伴關係，共同開發人工智慧驅動的工具，用於臨床前研究和藥物發現中的實驗設計、最佳化試劑選擇和資料解釋。
  • 2025年5月，QIAGEN簽署最終協議，收購人工智慧軟體公司Genoox。 Genoox致力於簡化複雜基因檢測的分析流程。該協議將把Genoox的雲端基礎平台Franklin納入QIAGEN Digital Insights產品組合，鞏固QIAGEN在臨床基因組學和基因解讀領域的領先地位。
  • 2025年 2月，QIAGEN 宣佈在澳洲墨爾本正式啟用一座新的資料中心，目的是加強公司在全球生物資訊學方面的能力，並擴大其在該地區的領先地位。

需求 - 促進因素、挑戰與機會

市場促進因素：

藥物發現領域對生物資訊學的需求日益成長 - 資料驅動和計算驅動的藥物發現模式的興起是推動全球生物資訊市場成長的主要因素。次世代定序、蛋白質體學、單細胞分析和代謝體學產生的多組體學資料的快速成長，顯著提升了對能夠整合、分析和解讀複雜生物資料集的生物資訊平台的需求。這些工具透過加深對疾病機制的理解、改善目標分子識別以及利用廣泛的基因組、蛋白質組和結構資料庫進行高效的虛擬篩檢，顯著增強了早期研究。分子對接、虛擬篩檢和基於人工智慧的電腦輔助藥物設計（CADD）的廣泛應用，透過減少傳統實驗流程所需的時間和成本，進一步推動了市場需求。諸如In Silico Medicine公司人工智慧設計的藥物INS018_055進入II期臨床試驗等具有里程碑意義的成功案例，凸顯了電腦輔助藥物發現的商業性價值以及業界日益成長的信心。此外，對更快、更安全研發路徑的需求推動了生物資訊學在藥物發現領域的應用日益廣泛，進而促使對預測演算法和藥物-疾病匹配平台的投資不斷成長。這些因素共同推動了生物資訊學與藥物研發的融合，帶動了生物資訊市場的強勁持續成長。

市場挑戰：

資料複雜性和異質性：來自基因組學、轉錄組學、蛋白質組學、成像和臨床系統的快速成長的多維資料集，給整合、分析和標準化帶來了巨大挑戰。資料複雜性和異質性仍然是生物資訊學市場的主要阻礙因素。各機構必須投入巨資購置先進的運算工具、高效能基礎設施和專業知識，才能管理大型且多樣化的資料類型，包括單一檔案大小達 100-200 GB 的全基因測序檔案、英國生物銀行等Petabyte級資料庫，以及包含數百萬個細胞的單細胞資料集。從 DNA 到臨床記錄，生物資訊的多維特性進一步加劇了資料協調和因果關係解讀的複雜性。由於平台差異、批次效應和取樣方法不一致，研究人員往往需要花費數週時間來協調多體學資料。異質資料格式（FASTQ、BAM、DICOM、mzML、PDB）和不相容的臨床標準（HL7、FHIR、ICD-10、SNOMED）阻礙了互通性，而資料品質參差不齊和缺乏標準化元資料則增加了預處理負擔。蛋白質體學實驗室和大型聯盟（例如ELIXIR和GA4GH）經常報告這些問題。即使是Pfizer和Novartis等大型製藥企業，由於整合多體學、影像學和真實世界資料集的挑戰，在早期研發階段也面臨數月的延誤。總而言之，這些問題對可擴展性構成了重大障礙，延長了研究週期，並限制了生物資訊解決方案的廣泛應用。這使得資料複雜性和異質性成為市場成長的主要阻礙因素。

市場機會

總體基因體學的新興角色 - 生物資訊學在總體基因體學中扮演著日益重要的角色，它提供了分析大型複雜資料集、識別微生物群落及其功能所需的計算能力。從16S rRNA定序到鳥槍法宏基因組學的轉變加速了這一趨勢，實現了物種和菌株等級的解析度、功能通路註釋以及抗菌素抗藥性的即時追蹤。諸如2024年Bioinformatics Journal一項研究中重點介紹的Nanometa Live平台等先進工具，現在可以透過互動式和自動化工作流程支援病原體的即時檢測。在臨床診斷領域，Oxford Nanopore Technologies公司的mNGS流程和可攜式定序儀能夠快速現場鑑定細菌、病毒和真菌，改善疫情爆發和混合感染的應對措施。在環境和農業領域，元基因組生物資訊學正被應用於水質監測、土壤和海洋微生物組圖譜繪製以及靶向生物肥料的開發。多體學資料的日益整合將進一步擴大其在酶發現、生質燃料生產、生物修復和治療方法開發等領域的應用，使總體基因體學成為全球生物資訊市場中快速成長的機會。

這份報告能為貴公司帶來哪些價值？

產品與創新策略：全球生物資訊市場已根據產品和服務、產業、應用和地區等各種類別進行了詳細細分，這有助於讀者清楚地了解哪些細分市場佔據最大佔有率，以及預計未來幾年它們將在哪些領域成長。

成長與行銷策略：產品發布是主要發展的主要因素，約佔2023年 1月至2025年 11月全球生物資訊市場所有發展總量的51%。

競爭策略：全球生物資訊市場擁有眾多產品系列完善的成熟企業。本研究分析和介紹的全球生物資訊學市場主要參與者均為提供生物資訊學產品和服務的成熟公司。

調查方法

市場設計與檢驗中的關鍵考慮因素與假設

  • 為估算全球市場規模，考慮了2023年至2035年期間，其中2024年為基準年，2025年至2035年為預測期。
  • 本報告的範圍是根據全球各公司專家的見解精心製定的，它對生物資訊市場的產品和服務進行了全面的市場研究。
  • 預計生物資訊學的市場貢獻將在未來穩步成長，該預測是基於對現有解決方案的歷史分析。
  • 公司收入資料來自2023 會計年度和2024 會計年度的年度報告。對於私人公司，收入是根據一手調查資料、資金籌措歷史、市場聯繫和業務表現估算的。
  • 本報告基於現有的生物資訊學產品和服務繪製了市場圖。報告中已識別並介紹了該領域的主要企業及其重要產品和服務。

主要市場參與企業及競爭摘要

本次評選的公司是根據對公司覆蓋範圍、產品系列和市場滲透率的分析所得出的資訊而選定的。

該市場的主要企業有：

  • Thermo Fisher Scientific Inc.
  • Eurofins Scientific
  • Illumina, Inc.
  • QIAGEN
  • ArrayGen Technologies Pvt. Ltd.
  • Source BioScience

目錄

執行摘要

第1章 全球生物資訊學市場：產業展望

  • 市場趨勢：當前及未來影響評估
    • 人工智慧和機器學習在生物資訊解決方案中的策略整合
    • 將多體學資料整合到生物資訊市場
    • 量子計算變革生物資訊學
  • 監管狀態
  • 定價分析
  • 市場動態
    • 市場促進因素
    • 市場挑戰
    • 市場機會

第2章 全球生物資訊市場（依產品和服務，十億美元，2023-2035年）

  • 生物資訊軟體和工具
  • 生物資訊服務
    • 定序和資料生成服務
    • 資料庫建置和管理服務
    • 資料分析與解釋服務
    • 其他

第3章 全球生物資訊市場（依產業，十億美元，2023-2035年）

  • 醫學生物技術
  • 動物生物技術
  • 植物生物技術
  • 法醫學生物技術
  • 其他

第4章 全球生物資訊市場（依應用領域，十億美元，2023-2035年）

  • 基因組學
  • 蛋白質體學
  • 轉錄組學
  • 代謝體學
  • 其他

第5章 全球生物資訊市場（依地區，十億美元，2023-2035年）

  • 北美洲
  • 歐洲
  • 亞太地區
  • 其他地區

第6章 競爭基準化分析與公司概況

  • 2023-2025年主要策略與發展
  • 關鍵發展分析（依公司），2023-2025年
  • 公司簡介
    • Agilent Technologies
    • ArrayGen Technologies Pvt. Ltd.
    • BGI Group
    • Crown Bioscience
    • Danaher Corporation（Genedata AG）
    • DNASTAR
    • Eurofins Scientific
    • Fios Genomics
    • Illumina, Inc.
    • MedGenome
    • Nucleome Informatics
    • Psomagen Inc.
    • QIAGEN
    • SOPHiA GENETICS
    • Thermo Fisher Scientific Inc.

第7章 調查方法

Product Code: BHD3397SA

This report can be delivered within 1 working day.

Introduction of the Bioinformatics Market

The global bioinformatics market, initially valued at $14.23 billion in 2024, is projected to witness substantial growth, surging to $55.54 billion by 2035, marking a remarkable compound annual growth rate (CAGR) of 13.21% over the period from 2025 to 2035.

KEY MARKET STATISTICS
Forecast Period2025 - 2035
2025 Evaluation$16.06 Billion
2035 Forecast$55.54 Billion
CAGR13.21%

Bioinformatics is an interdisciplinary field that combines biology, chemistry, mathematics, statistics, and computer science to analyze complex biological data. It is essential for understanding the structure, function, and evolution of biological molecules and systems, playing a key role in identifying genetic causes of diseases, analyzing gene expression, and studying protein interactions. Bioinformatics is also crucial in drug discovery, personalized medicine, and the exploration of metabolic pathways. The rapid growth of genomic data, driven by advances in next-generation sequencing technologies, has significantly boosted the demand for bioinformatics tools. Additionally, bioinformatics is increasingly applied in precision medicine. The field's importance continues to rise, with ongoing advancements in AI and machine learning further enhancing the accuracy and speed of data analysis, making bioinformatics a critical component in the future of healthcare, genomics, and life sciences research.

Market Introduction

The bioinformatics market has been rapidly advancing, driven by technological innovations and increasing investments in genomics and personalized medicine. Key companies such as Illumina Inc., Thermo Fisher Scientific Inc., and QIAGEN are at the forefront of bioinformatics solutions, offering cutting-edge sequencing platforms and data analysis tools that are transforming the healthcare and pharmaceutical industries. Strategic collaborations and acquisitions are also playing a significant role in market growth. For instance, Illumina has expanded its footprint in the APAC region, while Thermo Fisher Scientific Inc. continues to innovate with cloud-based bioinformatics solutions for genomic data analysis. Additionally, companies like Tempus and 23andMe are integrating bioinformatics tools for precision medicine and consumer genetic testing, driving the adoption of bioinformatics across diverse applications. These developments highlight the increasing demand for advanced bioinformatics solutions, fueling innovation and expanding applications in genomics, drug discovery, and personalized healthcare.

Industrial Impact

The bioinformatics market has been experiencing a significant transformation, largely driven by key players such as Thermo Fisher Scientific Inc., Illumina, Inc., Agilent Technologies, and QIAGEN, who are at the forefront of advancing bioinformatics technologies. These leaders are pushing the boundaries of innovation, integrating cutting-edge technologies such as Artificial Intelligence (AI), machine learning, and cloud computing to enhance bioinformatics capabilities. The integration of AI in bioinformatics is revolutionizing the analysis of complex biological data, enabling researchers and clinicians to make faster, more accurate insights into genomics, proteomics, and personalized medicine.

AI-driven bioinformatics tools are automating data processing and analysis, reducing human error and expediting research timelines. For example, AI models can analyze vast genomic datasets to identify patterns and mutations linked to diseases, which would take traditional methods much longer to uncover. This rapid analysis is crucial for advancing precision medicine, where treatments are tailored to the genetic profile of individual patients. Additionally, machine learning algorithms are enhancing predictive models, allowing for more accurate forecasts in drug development and patient outcomes.

The adoption of cloud computing in bioinformatics has also been transformative, enabling seamless data sharing, storage, and collaboration across global research teams. This has not only accelerated research and development in genomics and drug discovery but also lowered the barrier to entry for smaller labs and institutions by providing scalable, cost-effective solutions for big data analysis. Furthermore, the synergy of these technologies is improving patient care by providing healthcare providers with actionable insights into genetic predispositions, optimizing treatment plans, and enhancing the overall efficiency of healthcare delivery.

Market Segmentation:

Segmentation 1: By Product and Services

  • Bioinformatics Software and Tools
  • Bioinformatics Services

Bioinformatics Software and Tools to Dominate the Bioinformatics Market (by Product and Services)

Based on product and services, the global bioinformatics market was led by bioinformatics software and tools, which held a 61.7% share in 2024. Bioinformatics software and tools play a critical role in managing, analyzing, and interpreting complex biological data. With the increasing volume of data from technologies like next-generation sequencing (NGS), these tools enable efficient data management and accelerate the analysis process. Software like BLAST and GATK streamline tasks such as sequence alignment, variant calling, and mutation detection, which are essential for genomics and personalized medicine. Furthermore, the integration of AI and machine learning enhances the accuracy and predictive power of analyses, which helps in detecting genetic variants and providing personalized treatment recommendations. Cloud-based platforms like Illumina's BaseSpace Sequence Hub and Galaxy have further democratized bioinformatics by enabling collaboration and providing scalable solutions for data sharing and storage. These tools reduce manual effort, improve speed, and ensure more precise outcomes in research and clinical settings, making them indispensable for advancing fields such as genomics, drug discovery, and precision medicine.

Segmentation 2: By Sector

  • Medical Biotechnology
  • Animal Biotechnology
  • Plant Biotechnology
  • Forensic Biotechnology
  • Others

Medical Biotechnology to Dominate the Bioinformatics Market (by Sector)

Based on sector, medical biotechnology dominated the global bioinformatics market with a 55.2% share in 2024. Medical biotechnology dominates the bioinformatics market because it relies heavily on bioinformatics tools to advance areas like gene therapy, personalized medicine, and drug development. Bioinformatics enables the analysis of large genomic datasets, allowing biotech companies to identify disease-related genetic mutations, biomarkers, and therapeutic targets. For example, Illumina's sequencing platforms are essential in medical biotechnology, providing accurate genomic data that drives advancements in diagnostics and treatment development. Tempus, a leader in precision medicine, uses bioinformatics to analyze genetic profiles of cancer patients, offering personalized treatment recommendations based on their unique mutations. Additionally, CRISPR-Cas9 gene editing, a key technology in medical biotech, depends on bioinformatics for precise gene targeting and validation. The combination of bioinformatics with medical biotechnology accelerates the development of targeted therapies, improving treatment outcomes and enhancing drug discovery processes. This synergy has made bioinformatics an integral part of medical biotechnology's success and growth.

Segmentation 3: By Application

  • Genomics
  • Proteomics
  • Transcriptomics
  • Metabolomics
  • Others

Genomics to Lead the Bioinformatics Market (by Application)

Based on application, genomics dominated the global bioinformatics market with a 39.7% share in 2024. Genomics dominates the bioinformatics market because it generates vast, complex datasets that require advanced bioinformatics tools for accurate analysis and interpretation. Bioinformatics is crucial in genomics for tasks such as sequencing, alignment, and variant calling, enabling the identification of genetic mutations and potential therapeutic targets. For instance, Illumina's sequencing platforms are central to genomic research and clinical applications, providing data that drives personalized medicine and drug development. Companies like Tempus leverage bioinformatics to analyze genomic data for precision cancer treatment, tailoring therapies based on genetic mutations. Additionally, bioinformatics tools are integral to large-scale genomic projects like the Human Genome Project and the 1000 Genomes Project, which have expanded our understanding of genetics and laid the foundation for modern genomics. As genomic technologies continue to advance, bioinformatics remains essential for analyzing, interpreting, and applying genomic data, solidifying genomics' dominance in the bioinformatics market.

Segmentation 4: By Region

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Rest-of-Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Rest-of-Asia-Pacific
  • Rest-of-the-World

North America to Witness the Highest Growth in the Bioinformatics Market (by Region)

The bioinformatics market in North America dominates globally, accounting for approximately 43.5% share in 2024. North America dominates the bioinformatics market due to its strong infrastructure, significant R&D investments, and the presence of leading companies like Illumina, Thermo Fisher Scientific, and QIAGEN. However, the Asia-Pacific region is the fastest-growing market in bioinformatics due to its expanding healthcare infrastructure, increasing investments in biotechnology and genomics, and a rising demand for personalized medicine. Countries like China, India, and Japan are heavily investing in genomic research and bioinformatics technologies to support their growing healthcare needs. The region's large, diverse population provides a wealth of data for genomic studies, creating opportunities for advancements in precision medicine and drug development.

Recent Developments in the Global Bioinformatics Market

  • In September 2025, Thermo Fisher Scientific Inc. announced a strategic partnership with BenchSci to develop AI-powered tools for experimental design, optimized reagent selection, and data interpretation in preclinical research and drug discovery.
  • In May 2025, QIAGEN signed a definitive agreement to acquire Genoox, an AI-powered software company that streamlines complex genetic test analysis. The deal adds Franklin, Genoox's cloud-based platform, to the QIAGEN Digital Insights portfolio, bolstering QIAGEN's leadership in clinical genomics and genetic interpretation.
  • In February 2025, QIAGEN announced the official launch of its new data center in Melbourne, Australia, aimed at enhancing the company's global bioinformatics capabilities and reinforcing its leadership in the region.

Demand - Drivers, Challenges, and Opportunities

Market Drivers:

Growing Demand for Bioinformatics in Drug Discovery: The increasing shift toward data-driven and computational drug development is a primary driver accelerating the growth of the global bioinformatics market. The rapid expansion of multi-omics data generated through next-generation sequencing, proteomics, single-cell analysis, and metabolomics has created a critical need for bioinformatics platforms that can integrate, analyze, and interpret complex biological datasets. These tools significantly enhance early-stage research by deepening understanding of disease mechanisms, improving target identification, and enabling efficient virtual screening using extensive genomic, proteomic, and structural databases. The widespread adoption of molecular docking, virtual screening, and AI-enabled computer-aided drug design (CADD) further amplifies market demand, as these technologies reduce both the time and cost associated with traditional experimental workflows. High-impact examples, such as Insilico Medicine's AI-designed INS018_055 advancing to Phase II trials, highlight the commercial value and growing industry confidence in computational drug discovery. Additionally, the rising use of bioinformatics for drug repurposing, driven by the need for faster, lower-risk development pathways, is expanding investment in predictive algorithms and drug-disease matching platforms. Together, these factors underscore how the increasing integration of bioinformatics into pharmaceutical R&D is driving robust and sustained growth in the bioinformatics market.

Market Challenges:

Data Complexity and Heterogeneity: Data complexity and heterogeneity remain major restraints in the bioinformatics market, as rapidly expanding and multi-dimensional datasets from genomics, transcriptomics, proteomics, imaging, and clinical systems are difficult to integrate, analyze, and standardize. Organizations must invest heavily in advanced computational tools, high-performance infrastructure, and specialized expertise to manage large and diverse data types such as whole-genome sequencing files reaching 100-200 GB each, multi-petabyte repositories like the U.K. Biobank, and single-cell datasets containing millions of cells. The multi-dimensional nature of biological information, spanning DNA to clinical records, further complicates harmonization and causal interpretation, with researchers often spending weeks aligning multi-omics layers due to cross-platform variability, batch effects, and inconsistent sampling methods. Heterogeneous data formats (FASTQ, BAM, DICOM, mzML, PDB) and incompatible clinical standards (HL7, FHIR, ICD-10, SNOMED) hinder interoperability, while variable data quality and lack of standardized metadata add to preprocessing burdens, issues frequently reported by proteomics labs and large consortia like ELIXIR and GA4GH. Even major pharmaceutical companies such as Pfizer and Novartis face delays of months in early-stage development due to challenges in integrating multi-omics, imaging, and real-world clinical datasets. Collectively, these issues create significant barriers to scalability, prolong research timelines, and restrict wider adoption of bioinformatics solutions, making data complexity and heterogeneity key restraints on market growth.

Market Opportunities

Emerging Role in Metagenomics: Bioinformatics is becoming increasingly vital in metagenomics, providing the computational power needed to analyze large, complex datasets and identify microbial communities and their functions. The shift from 16S rRNA sequencing to shotgun metagenomics has accelerated this trend, enabling species- and strain-level resolution, functional pathway annotation, and real-time tracking of antimicrobial resistance. Advanced tools such as the Nanometa Live platform, highlighted in a 2024 Bioinformatics Journal study, now support real-time pathogen detection through interactive and automated workflows. In clinical diagnostics, mNGS pipelines and portable sequencers from Oxford Nanopore Technologies allow rapid, on-site identification of bacteria, viruses, and fungi, improving responses during outbreaks and mixed infections. Environmental and agricultural sectors are adopting metagenomic bioinformatics to monitor water quality, map soil and ocean microbiomes, and develop targeted biofertilizers. Growing integration of multi-omics data is further expanding applications in enzyme discovery, biofuel production, bioremediation, and therapeutic development, positioning metagenomics as a rapidly growing opportunity within the global bioinformatics market.

How can this report add value to an organization?

Product/Innovation Strategy: The global bioinformatics market has been extensively segmented based on various categories, such as product and services, sector, application, and region. This can help readers get a clear overview of which segments account for the largest share and which ones are well-positioned to grow in the coming years.

Growth/Marketing Strategy: Product launches have accounted for the majority of key developments, comprising nearly 51% of the total developments in the global bioinformatics market between January 2023 and November 2025.

Competitive Strategy: The global bioinformatics market has numerous established players with product portfolios. Key players in the global bioinformatics market, analyzed and profiled in the study, include established players offering products and services for bioinformatics.

Methodology

Key Considerations and Assumptions in Market Engineering and Validation

  • Years from 2023 to 2035 have been considered for the global market size estimation, 2024 has been considered as the base year, and 2025 to 2035 as the forecast period.
  • The scope of this report has been carefully developed based on insights from experts across various companies worldwide. It presents a comprehensive market study of the products and services withing bioinformatics market.
  • The market contribution of bioinformatics is anticipated to grow steadily in the future, with projections based on historical analysis of available solutions.
  • Revenues from companies have been sourced from their annual reports for FY2023 and FY2024. For private companies, revenue estimates have been derived from primary research inputs, funding history, market collaborations, and operational performance.
  • The market has been mapped based on the existing bioinformatics products and services. Key companies with significant offerings in this field have been identified and profiled in this report.

Primary Research

The primary sources involve industry experts in bioinformatics, including the market players offering products and services. Resources such as CEOs, vice presidents, and marketing directors have been interviewed to obtain and verify both qualitative and quantitative aspects of this research study.

The key data points taken from the primary sources include:

  • validation and triangulation of all the numbers and graphs
  • validation of report segmentations and key qualitative findings
  • understanding the competitive landscape and business model
  • current and proposed production values of a product by market players
  • validation of the numbers of different segments of the market in focus
  • percentage split of individual markets for regional analysis

Secondary Research

Open Sources

  • Certified publications, articles from recognized authors, white papers, directories, and major databases, among others
  • Annual reports, SEC filings, and investors' presentations of the leading market players
  • Company websites and a detailed study of their product portfolio
  • Gold standard magazines, journals, white papers, press releases, and news articles
  • Paid databases

The key data points taken from the secondary sources include:

  • segmentations and percentage shares
  • data for market value
  • key industry trends of the top players in the market
  • qualitative insights into various aspects of the market, key trends, and emerging areas of innovation
  • quantitative data for mathematical and statistical calculations

Key Market Players and Competition Synopsis

The companies profiled have been selected based on inputs gathered from an analysis of company coverage, product portfolio, and market penetration.

Some prominent names established in this market are:

  • Thermo Fisher Scientific Inc.
  • Eurofins Scientific
  • Illumina, Inc.
  • QIAGEN
  • ArrayGen Technologies Pvt. Ltd.
  • Source BioScience

Table of Contents

Executive Summary

Scope and Definition

1 Global Bioinformatics Market: Industry Outlook

  • 1.1 Market Trends: Current and Future Impact Assessment
    • 1.1.1 Strategic Integration of AI and ML in Bioinformatics Solutions
    • 1.1.2 Integration of Multi-Omics Data in the Bioinformatics Market
    • 1.1.3 Quantum Computing to Transform Bioinformatics
  • 1.2 Regulatory Landscape
  • 1.3 Pricing Analysis
  • 1.4 Market Dynamics
    • 1.4.1 Market Drivers
      • 1.4.1.1 Rising Private and Public Investments in the Bioinformatics Industry
      • 1.4.1.2 Growing Demand for Bioinformatics in Drug Discovery
      • 1.4.1.3 Expanding Genomic Data Propelling the Demand for Bioinformatics Tools
    • 1.4.2 Market Challenges
      • 1.4.2.1 Data Complexity and Heterogeneity Limiting Bioinformatics Growth
      • 1.4.2.2 Ethical and Data Privacy Challenges Impacting Bioinformatics Adoption
    • 1.4.3 Market Opportunities
      • 1.4.3.1 Rising Importance of Metagenomics Offering Growth Potential for Bioinformatics

2 Global Bioinformatics Market, by Product and Services, $Billion, 2023-2035

  • 2.1 Bioinformatics Software and Tools
  • 2.2 Bioinformatics Services
    • 2.2.1 Sequencing and Data Generation Services
    • 2.2.2 Database Construction and Management Services
    • 2.2.3 Data Analysis and Interpretation Services
    • 2.2.4 Others

3 Global Bioinformatics Market, by Sector, $Billion, 2023-2035

  • 3.1 Medical Biotechnology
  • 3.2 Animal Biotechnology
  • 3.3 Plant Biotechnology
  • 3.4 Forensic Biotechnology
  • 3.5 Others

4 Global Bioinformatics Market, by Application, $Billion, 2023-2035

  • 4.1 Genomics
  • 4.2 Proteomics
  • 4.3 Transcriptomics
  • 4.4 Metabolomics
  • 4.5 Other Applications

5 Global Bioinformatics Market, by Region, $Billion, 2023-2035

  • 5.1 North America
    • 5.1.1 Regional Overview
    • 5.1.2 Driving Factors for Market Growth
    • 5.1.3 Factors Challenging the Market
    • 5.1.4 Market Sizing and Forecast
      • 5.1.4.1 North America Bioinformatics Market (by Product and Services)
      • 5.1.4.2 North America Bioinformatics Market (by Application)
      • 5.1.4.3 North America Bioinformatics Market (by Sector)
      • 5.1.4.4 North America Bioinformatics Market (by Country)
        • 5.1.4.4.1 U.S.
          • 5.1.4.4.1.1 Country Overview
          • 5.1.4.4.1.2 Driving Factors Market Growth
          • 5.1.4.4.1.3 Factors Challenging the Market
          • 5.1.4.4.1.4 Analyst View
          • 5.1.4.4.1.5 Market Sizing and Forecast
        • 5.1.4.4.2 Canada
          • 5.1.4.4.2.1 Country Overview
          • 5.1.4.4.2.2 Driving Factors Market Growth
          • 5.1.4.4.2.3 Factors Challenging the Market
          • 5.1.4.4.2.4 Analyst View
          • 5.1.4.4.2.5 Market Sizing and Forecast
  • 5.2 Europe
    • 5.2.1 Regional Overview
    • 5.2.2 Driving Factors for Market Growth
    • 5.2.3 Factors Challenging the Market
    • 5.2.4 Analyst View
    • 5.2.5 Market Sizing and Forecast
      • 5.2.5.1 Europe Bioinformatics Market (by Product and Services)
      • 5.2.5.2 Europe Bioinformatics Market (by Application)
      • 5.2.5.3 Europe Bioinformatics Market (by Sector)
      • 5.2.5.4 Europe Bioinformatics Market (by Country)
        • 5.2.5.4.1 U.K.
          • 5.2.5.4.1.1 Country Overview
          • 5.2.5.4.1.2 Driving Factors Market Growth
          • 5.2.5.4.1.3 Factors Challenging the Market
          • 5.2.5.4.1.4 Analyst View
          • 5.2.5.4.1.5 Market Sizing and Forecast
        • 5.2.5.4.2 Germany
          • 5.2.5.4.2.1 Country Overview
          • 5.2.5.4.2.2 Driving Factors Market Growth
          • 5.2.5.4.2.3 Factors Challenging the Market
          • 5.2.5.4.2.4 Analyst View
          • 5.2.5.4.2.5 Market Sizing and Forecast
        • 5.2.5.4.3 France
          • 5.2.5.4.3.1 Country Overview
          • 5.2.5.4.3.2 Driving Factors Market Growth
          • 5.2.5.4.3.3 Factors Challenging the Market
          • 5.2.5.4.3.4 Analyst View
          • 5.2.5.4.3.5 Market Sizing and Forecast
        • 5.2.5.4.4 Italy
          • 5.2.5.4.4.1 Country Overview
          • 5.2.5.4.4.2 Driving Factors Market Growth
          • 5.2.5.4.4.3 Factors Challenging the Market
          • 5.2.5.4.4.4 Analyst View
          • 5.2.5.4.4.5 Market Sizing and Forecast
        • 5.2.5.4.5 Spain
          • 5.2.5.4.5.1 Country Overview
          • 5.2.5.4.5.2 Driving Factors Market Growth
          • 5.2.5.4.5.3 Factors Challenging the Market
          • 5.2.5.4.5.4 Analyst View
          • 5.2.5.4.5.5 Market Sizing and Forecast
        • 5.2.5.4.6 Rest-of-Europe
          • 5.2.5.4.6.1 Regional Overview
          • 5.2.5.4.6.2 Driving Factors Market Growth
          • 5.2.5.4.6.3 Factors Challenging the Market
          • 5.2.5.4.6.4 Analyst View
          • 5.2.5.4.6.5 Market Sizing and Forecast
  • 5.3 Asia-Pacific
    • 5.3.1 Regional Overview
    • 5.3.2 Driving Factors for Market Growth
    • 5.3.3 Factors Challenging the Market
    • 5.3.4 Market Sizing and Forecast
      • 5.3.4.1 Asia-Pacific Bioinformatics Market (by Product and Services)
      • 5.3.4.2 Asia-Pacific Bioinformatics Market (by Application)
      • 5.3.4.3 Asia-Pacific Bioinformatics Market (by Sector)
      • 5.3.4.4 Asia-Pacific Bioinformatics Market (by Country)
        • 5.3.4.4.1 China
          • 5.3.4.4.1.1 Country Overview
          • 5.3.4.4.1.2 Driving Factors Market Growth
          • 5.3.4.4.1.3 Factors Challenging the Market
          • 5.3.4.4.1.4 Analyst View
          • 5.3.4.4.1.5 Market Sizing and Forecast
        • 5.3.4.4.2 Japan
          • 5.3.4.4.2.1 Country Overview
          • 5.3.4.4.2.2 Driving Factors Market Growth
          • 5.3.4.4.2.3 Factors Challenging the Market
          • 5.3.4.4.2.4 Analyst View
          • 5.3.4.4.2.5 Market Sizing and Forecast
        • 5.3.4.4.3 India
          • 5.3.4.4.3.1 Country Overview
          • 5.3.4.4.3.2 Driving Factors Market Growth
          • 5.3.4.4.3.3 Factors Challenging the Market
          • 5.3.4.4.3.4 Analyst View
          • 5.3.4.4.3.5 Market Sizing and Forecast
        • 5.3.4.4.4 South Korea
          • 5.3.4.4.4.1 Country Overview
          • 5.3.4.4.4.2 Driving Factors Market Growth
          • 5.3.4.4.4.3 Factors Challenging the Market
          • 5.3.4.4.4.4 Analyst View
          • 5.3.4.4.4.5 Market Sizing and Forecast
        • 5.3.4.4.5 Australia
          • 5.3.4.4.5.1 Country Overview
          • 5.3.4.4.5.2 Driving Factors Market Growth
          • 5.3.4.4.5.3 Factors Challenging the Market
          • 5.3.4.4.5.4 Analyst View
          • 5.3.4.4.5.5 Market Sizing and Forecast
        • 5.3.4.4.6 Rest-of-Asia-Pacific
          • 5.3.4.4.6.1 Country Overview
          • 5.3.4.4.6.2 Driving Factors Market Growth
          • 5.3.4.4.6.3 Factors Challenging the Market
          • 5.3.4.4.6.4 Analyst View
          • 5.3.4.4.6.5 Market Sizing and Forecast
  • 5.4 Rest-of-the-World
    • 5.4.1 Regional Overview
    • 5.4.2 Driving Factors for Market Growth
    • 5.4.3 Factors Challenging the Market
    • 5.4.4 Market Sizing and Forecast
      • 5.4.4.1 Rest-of-the-World Bioinformatics Market (by Product and Services)
      • 5.4.4.2 Rest-of-the-World Bioinformatics Market (by Application)
      • 5.4.4.3 Rest-of-the-World Bioinformatics Market (by Sector)

6 Competitive Benchmarking and Company Profiles

  • 6.1 Key Strategies and Developments, 2023-2025
  • 6.2 Key Developments Analysis (by Company), 2023-2025
  • 6.3 Company Profiles
    • 6.3.1 Agilent Technologies
      • 6.3.1.1 Overview
      • 6.3.1.2 Top Products/Product Portfolio
      • 6.3.1.3 Top Competitors
      • 6.3.1.4 Target Customers
      • 6.3.1.5 Key Personnel
      • 6.3.1.6 Analyst View
    • 6.3.2 ArrayGen Technologies Pvt. Ltd.
      • 6.3.2.1 Overview
      • 6.3.2.2 Top Products/Product Portfolio
      • 6.3.2.3 Top Competitors
      • 6.3.2.4 Target Customers
      • 6.3.2.5 Key Personnel
      • 6.3.2.6 Analyst View
    • 6.3.3 BGI Group
      • 6.3.3.1 Overview
      • 6.3.3.2 Top Products/Product Portfolio
      • 6.3.3.3 Top Competitors
      • 6.3.3.4 Target Customers
      • 6.3.3.5 Key Personnel
      • 6.3.3.6 Analyst View
    • 6.3.4 Crown Bioscience
      • 6.3.4.1 Overview
      • 6.3.4.2 Top Products/Product Portfolio
      • 6.3.4.3 Top Competitors
      • 6.3.4.4 Target Customers
      • 6.3.4.5 Key Personnel
      • 6.3.4.6 Analyst View
    • 6.3.5 Danaher Corporation (Genedata AG)
      • 6.3.5.1 Overview
      • 6.3.5.2 Top Products/Product Portfolio
      • 6.3.5.3 Top Competitors
      • 6.3.5.4 Target Customers
      • 6.3.5.5 Key Personnel
      • 6.3.5.6 Analyst View
    • 6.3.6 DNASTAR
      • 6.3.6.1 Overview
      • 6.3.6.2 Top Products/Product Portfolio
      • 6.3.6.3 Top Competitors
      • 6.3.6.4 Target Customers
      • 6.3.6.5 Key Personnel
      • 6.3.6.6 Analyst View
    • 6.3.7 Eurofins Scientific
      • 6.3.7.1 Overview
      • 6.3.7.2 Top Products/Product Portfolio
      • 6.3.7.3 Top Competitors
      • 6.3.7.4 Target Customers
      • 6.3.7.5 Key Personnel
      • 6.3.7.6 Analyst View
    • 6.3.8 Fios Genomics
      • 6.3.8.1 Overview
      • 6.3.8.2 Top Products/Product Portfolio
      • 6.3.8.3 Top Competitors
      • 6.3.8.4 Target Customers
      • 6.3.8.5 Key Personnel
      • 6.3.8.6 Analyst View
    • 6.3.9 Illumina, Inc.
      • 6.3.9.1 Overview
      • 6.3.9.2 Top Products/Product Portfolio
      • 6.3.9.3 Top Competitors
      • 6.3.9.4 Target Customers
      • 6.3.9.5 Key Personnel
      • 6.3.9.6 Analyst View
    • 6.3.10 MedGenome
      • 6.3.10.1 Overview
      • 6.3.10.2 Top Products/Product Portfolio
      • 6.3.10.3 Top Competitors
      • 6.3.10.4 Target Customers
      • 6.3.10.5 Key Personnel
      • 6.3.10.6 Analyst View
    • 6.3.11 Nucleome Informatics
      • 6.3.11.1 Overview
      • 6.3.11.2 Top Products/Product Portfolio
      • 6.3.11.3 Top Competitors
      • 6.3.11.4 Target Customers
      • 6.3.11.5 Key Personnel
      • 6.3.11.6 Analyst View
    • 6.3.12 Psomagen Inc.
      • 6.3.12.1 Overview
      • 6.3.12.2 Top Products/Product Portfolio
      • 6.3.12.3 Top Competitors
      • 6.3.12.4 Target Customers
      • 6.3.12.5 Key Personnel
      • 6.3.12.6 Analyst View
    • 6.3.13 QIAGEN
      • 6.3.13.1 Overview
      • 6.3.13.2 Top Products/Product Portfolio
      • 6.3.13.3 Top Competitors
      • 6.3.13.4 Target Customers
      • 6.3.13.5 Key Personnel
      • 6.3.13.6 Analyst View
    • 6.3.14 SOPHiA GENETICS
      • 6.3.14.1 Overview
      • 6.3.14.2 Top Products/Product Portfolio
      • 6.3.14.3 Top Competitors
      • 6.3.14.4 Target Customers
      • 6.3.14.5 Key Personnel
      • 6.3.14.6 Analyst View
    • 6.3.15 Thermo Fisher Scientific Inc.
      • 6.3.15.1 Overview
      • 6.3.15.2 Top Products/Product Portfolio
      • 6.3.15.3 Top Competitors
      • 6.3.15.4 Target Customers
      • 6.3.15.5 Key Personnel
      • 6.3.15.6 Analyst View

7 Research Methodology

  • 7.1 Data Sources
    • 7.1.1 Primary Data Sources
    • 7.1.2 Secondary Data Sources
    • 7.1.3 Data Triangulation
  • 7.2 Market Estimation and Forecast

List of Figures

  • Figure 1: Global Bioinformatics Market (by Scenario), $Billion, 2024, 2025, and 2035
  • Figure 2: Bioinformatics Market (by Product and Services), $Billion, 2024, 2029, and 2035
  • Figure 3: Bioinformatics Market (by Sector), $Billion, 2024, 2029, and 2035
  • Figure 4: Bioinformatics Market (by Application), $Billion, 2024, 2029, and 2035
  • Figure 5: Global Bioinformatics Market, $Billion, 2024 and 2035
  • Figure 6: Global Bioinformatics Market (by Product and Services), $Billion, 2024, 2029, and 2035
  • Figure 7: Global Bioinformatics Market (Bioinformatics Software and Tools), $Billion, 2023-2035
  • Figure 8: Global Bioinformatics Market (by Bioinformatics Services), $Billion, 2023-2035
  • Figure 9: Global Bioinformatics Market (Sequencing and Data Generation Services), $Billion, 2023-2035
  • Figure 10: Global Bioinformatics Market (Database Construction and Management Services), $Billion, 2023-2035
  • Figure 11: Global Bioinformatics Market (Data Analysis and Interpretation Services), $Billion, 2023-2035
  • Figure 12: Global Bioinformatics Market (Others), $Billion, 2023-2035
  • Figure 13: Global Bioinformatics Market (by Sector), $Billion, 2024, 2029, and 2035
  • Figure 14: Global Bioinformatics Market (Medical Biotechnology), $Billion, 2023-2035
  • Figure 15: Global Bioinformatics Market (Animal Biotechnology), $Billion, 2023-2035
  • Figure 16: Global Bioinformatics Market (Plant Biotechnology), $Billion, 2023-2035
  • Figure 17: Global Bioinformatics Market (Forensic Biotechnology), $Billion, 2023-2035
  • Figure 18: Global Bioinformatics Market (Others), $Billion, 2023-2035
  • Figure 19: Global Bioinformatics Market (by Application), $Billion, 2024, 2029, and 2035
  • Figure 20: Global Bioinformatics Market (Genomics), $Billion, 2023-2035
  • Figure 21: Global Bioinformatics Market (Proteomics), $Billion, 2023-2035
  • Figure 22: Global Bioinformatics Market (Transcriptomics), $Billion, 2023-2035
  • Figure 23: Global Bioinformatics Market (Metabolomics), $Billion, 2023-2035
  • Figure 24: Global Bioinformatics Market (Other Applications), $Billion, 2023-2035
  • Figure 25: North America Bioinformatics Market, $Billion, 2023-2035
  • Figure 26: U.S. Bioinformatics Market, $Billion, 2023-2035
  • Figure 27: Canada Bioinformatics Market, $Billion, 2023-2035
  • Figure 28: Europe Bioinformatics Market, $Billion, 2023-2035
  • Figure 29: U.K. Bioinformatics Market, $Billion, 2023-2035
  • Figure 30: Germany Bioinformatics Market, $Billion, 2023-2035
  • Figure 31: France Bioinformatics Market, $Billion, 2023-2035
  • Figure 32: Italy Bioinformatics Market, $Billion, 2023-2035
  • Figure 33: Spain Bioinformatics Market, $Billion, 2023-2035
  • Figure 34: Rest-of-Europe Bioinformatics Market, $Billion, 2023-2035
  • Figure 35: Asia-Pacific Bioinformatics Market, $Billion, 2023-2035
  • Figure 36: China Bioinformatics Market, $Billion, 2023-2035
  • Figure 37: Japan Bioinformatics Market, $Billion, 2023-2035
  • Figure 38: India Bioinformatics Market, $Billion, 2023-2035
  • Figure 39: South Korea Bioinformatics Market, $Billion, 2023-2035
  • Figure 40: Australia Bioinformatics Market, $Billion, 2023-2035
  • Figure 41: Rest-of-Asia-Pacific Bioinformatics Market, $Billion, 2023-2035
  • Figure 42: Rest-of-the-World Bioinformatics Market, $Billion, 2023-2035
  • Figure 43: Key Strategies and Developments, January 2023-November 2025
  • Figure 44: Data Triangulation
  • Figure 45: Top-Down and Bottom-Up Approach
  • Figure 46: Assumptions and Limitations

List of Tables

  • Table 1: Market Snapshot
  • Table 2: Key Market Trends
  • Table 3: Global Bioinformatics Market, Regulatory Landscape
  • Table 4: Drivers, Challenges, and Opportunities: Current and Future Impact Assessment
  • Table 5: Some of the Public and Private Funding in the Bioinformatics Industry
  • Table 6: Global Bioinformatics Market (by Region), $Billion, 2023-2035
  • Table 7: North America Bioinformatics Market (by Product and Services), $Billion, 2023-2035
  • Table 8: North America Bioinformatics Market (by Application), $Billion, 2023-2035
  • Table 9: North America Bioinformatics Market (by Sector), $Billion, 2023-2035
  • Table 10: North America Bioinformatics Market (by Country), $Billion, 2023-2035
  • Table 11: U.S. Bioinformatics Market (by Product and Services), $Billion, 2023-2035
  • Table 12: U.S. Bioinformatics Market (by Application), $Billion, 2023-2035
  • Table 13: U.S. Bioinformatics Market (by Sector), $Billion, 2023-2035
  • Table 14: Canada Bioinformatics Market (by Product and Services), $Billion, 2023-2035
  • Table 15: Canada Bioinformatics Market (by Application), $Billion, 2023-2035
  • Table 16: Canada Bioinformatics Market (by Sector), $Billion, 2023-2035
  • Table 17: Europe Bioinformatics Market (by Product and Services), $Billion, 2023-2035
  • Table 18: Europe Bioinformatics Market (by Application), $Billion, 2023-2035
  • Table 19: Europe Bioinformatics Market (by Sector), $Billion, 2023-2035
  • Table 20: Europe Bioinformatics Market (by Country), $Billion, 2023-2035
  • Table 21: U.K. Bioinformatics Market (by Product and Services), $Billion, 2023-2035
  • Table 22: U.K. Bioinformatics Market (by Application), $Billion, 2023-2035
  • Table 23: U.K. Bioinformatics Market (by Sector), $Billion, 2023-2035
  • Table 24: Germany Bioinformatics Market (by Product and Services), $Billion, 2023-2035
  • Table 25: Germany Bioinformatics Market (by Application), $Billion, 2023-2035
  • Table 26: Germany Bioinformatics Market (by Sector), $Billion, 2023-2035
  • Table 27: France Bioinformatics Market (by Product and Services), $Billion, 2023-2035
  • Table 28: France Bioinformatics Market (by Application), $Billion, 2023-2035
  • Table 29: France Bioinformatics Market (by Sector), $Billion, 2023-2035
  • Table 30: Italy Bioinformatics Market (by Product and Services), $Billion, 2023-2035
  • Table 31: Italy Bioinformatics Market (by Application), $Billion, 2023-2035
  • Table 32: Italy Bioinformatics Market (by Sector), $Billion, 2023-2035
  • Table 33: Spain Bioinformatics Market (by Product and Services), $Billion, 2023-2035
  • Table 34: Spain Bioinformatics Market (by Application), $Billion, 2023-2035
  • Table 35: Spain Bioinformatics Market (by Sector), $Billion, 2023-2035
  • Table 36: Rest-of-Europe Bioinformatics Market (by Product and Services), $Billion, 2023-2035
  • Table 37: Rest-of-Europe Bioinformatics Market (by Application), $Billion, 2023-2035
  • Table 38: Rest-of-Europe Bioinformatics Market (by Sector), $Billion, 2024-3-2035
  • Table 39: Asia-Pacific Bioinformatics Market (by Product and Services), $Billion, 2023-2035
  • Table 40: Asia-Pacific Bioinformatics Market (by Application), $Billion, 2023-2035
  • Table 41: Asia-Pacific Bioinformatics Market (by Sector), $Billion, 2023-2035
  • Table 42: Asia-Pacific Bioinformatics Market (by Country), $Billion, 2023-2035
  • Table 43: China Bioinformatics Market (by Product and Services), $Billion, 2023-2035
  • Table 44: China Bioinformatics Market (by Application), $Billion, 2023-2035
  • Table 45: China Bioinformatics Market (by Sector), $Billion, 2023-2035
  • Table 46: Japan Bioinformatics Market (by Product and Services), $Billion, 2023-2035
  • Table 47: Japan Bioinformatics Market (by Application), $Billion, 2023-2035
  • Table 48: Japan Bioinformatics Market (by Sector), $Billion, 2023-2035
  • Table 49: India Bioinformatics Market (by Product and Services), $Billion, 2023-2035
  • Table 50: India Bioinformatics Market (by Application), $Billion, 2023-2035
  • Table 51: India Bioinformatics Market (by Sector), $Billion, 2023-2035
  • Table 52: South Korea Bioinformatics Market (by Product and Services), $Billion, 2023-2035
  • Table 53: South Korea Bioinformatics Market (by Application), $Billion, 2023-2035
  • Table 54: South Korea Bioinformatics Market (by Sector), $Billion, 2023-2035
  • Table 55: Australia Bioinformatics Market (by Product and Services), $Billion, 2023-2035
  • Table 56: Australia Bioinformatics Market (by Application), $Billion, 2023-2035
  • Table 57: Australia Bioinformatics Market (by Sector), $Billion, 2023-2035
  • Table 58: Rest-of-Asia-Pacific Bioinformatics Market (by Product and Services), $Billion, 2023-2035
  • Table 59: Rest-of-Asia-Pacific Bioinformatics Market (by Application), $Billion, 2023-2035
  • Table 60: Rest-of-Asia-Pacific Bioinformatics Market (by Sector), $Billion, 2023-2035
  • Table 61: Rest-of-the-World Bioinformatics Market (by Product and Services), $Billion, 2023-2035
  • Table 62: Rest-of-the-World Bioinformatics Market (by Application), $Billion, 2023-2035
  • Table 63: Rest-of-the-World Bioinformatics Market (by Sector), $Billion, 2023-2035
  • Table 64: Key Strategies and Developments, 2023-2025